comparemela.com

Latest Breaking News On - Present status - Page 6 : comparemela.com

TAGRISSO® (osimertinib) demonstrated 5 5-year median disease-free survival in the adjuvant treatment of patients with EGFR-mutated lung cancer

Nearly three in four patients treated with adjuvant TAGRISSO were alive and disease-free at four years Exploratory results showed TAGRISSO also reduced the risk of disease recurrence in the brain or spinal cord by 76% in patients with Stage II-IIIA disease

The 20th Major General Samir Sinha Memorial Lecture was organised by the United Service Institution (USI) of India

New Delhi [India], August 31 (ANI/PNN): The 20th Major General Samir Sinha Memorial Lecture was organised by the United Service Institution (USI) of India on 30 August 2022, wherein Air Chief Marshal VR Chaudhari, PVSM, AVSM, VM, ADC, Offg Chairman, COSC and the Chief of the Air Staff delivered a talk on 'Transformation of the Indian Air Force: Present Status and the Way Ahead. Late Maj Gen Samir Chandra Sinha, PVSM, a stalwart paratrooper, scholar and visionary, was the revered Director of the USI from November 1987 to 1996. The IAF, since its inception, has played a strategic role in our national defence and security. In a recently held global survey, the Indian Air Force has been ranked the world's third most powerful air power. The CAS covered the evolving geopolitical landscape in the backdrop of the Russia-Ukraine War, New Generation Warfare, China and Pakistan collusivity and its impact on India. He then elucidated comprehensively on the transformation of IAF as an aeros

U S FDA Approves IMBRUVICA® (ibrutinib) as First and Only BTKi Treatment for Pediatric Patients with Chronic Graft-Versus-Host Disease

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.